Reference number : 236-2016-2017-Q2-00340, amendment number : , agreement type : G, recipient legal name : Parkins, Michael D, recipient country : CA, recipient province : AB, recipient city : Calgary, recipient postal code : T2N 1N4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 347848.0, agreement start date : 2016-07-01, agreement end date : 2020-06-30, description english : Reverse engineering cystic fibrosis lung disease: use of a comprehensive biorepository in the exploration of disease pathogenesis and outcomes, description french : Reverse engineering cystic fibrosis lung disease: use of a comprehensive biorepository in the exploration of disease pathogenesis and outcomes, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2020-21), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2020-21), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada